86 related articles for article (PubMed ID: 16454188)
21. Antineuropathic effects of the antibiotic derivative spicamycin KRN5500.
Borsook D; Edwards AD
Pain Med; 2004 Mar; 5(1):104-8. PubMed ID: 14996243
[TBL] [Abstract][Full Text] [Related]
22. Manual and automatic extraction and high-performance liquid chromatographic determination of a spicamycin derivative, KRN5500, in rat plasma.
Yoshioka E; Morino M; Tanaka H; Shinkai H
J Chromatogr B Biomed Sci Appl; 1997 Apr; 691(2):371-5. PubMed ID: 9174273
[TBL] [Abstract][Full Text] [Related]
23. Antiproliferative activity in vitro and in vivo of the spicamycin analogue KRN5500 with altered glycoprotein expression in vitro.
Burger AM; Kaur G; Hollingshead M; Fischer RT; Nagashima K; Malspeis L; Duncan KL; Sausville EA
Clin Cancer Res; 1997 Mar; 3(3):455-63. PubMed ID: 9815705
[TBL] [Abstract][Full Text] [Related]
24. Optimization of (1,2-diamino-cyclohexane)platinum(II)-loaded polymeric micelles directed to improved tumor targeting and enhanced antitumor activity.
Cabral H; Nishiyama N; Kataoka K
J Control Release; 2007 Aug; 121(3):146-55. PubMed ID: 17628162
[TBL] [Abstract][Full Text] [Related]
25. cRGD-installed polymeric micelles loading platinum anticancer drugs enable cooperative treatment against lymph node metastasis.
Makino J; Cabral H; Miura Y; Matsumoto Y; Wang M; Kinoh H; Mochida Y; Nishiyama N; Kataoka K
J Control Release; 2015 Dec; 220(Pt B):783-91. PubMed ID: 26474676
[TBL] [Abstract][Full Text] [Related]
26. Deglycosylated bleomycin has the antitumor activity of bleomycin without pulmonary toxicity.
Burgy O; Wettstein G; Bellaye PS; Decologne N; Racoeur C; Goirand F; Beltramo G; Hernandez JF; Kenani A; Camus P; Bettaieb A; Garrido C; Bonniaud P
Sci Transl Med; 2016 Feb; 8(326):326ra20. PubMed ID: 26888428
[TBL] [Abstract][Full Text] [Related]
27. Biodegradable polymeric micelle-encapsulated quercetin suppresses tumor growth and metastasis in both transgenic zebrafish and mouse models.
Wu Q; Deng S; Li L; Sun L; Yang X; Liu X; Liu L; Qian Z; Wei Y; Gong C
Nanoscale; 2013 Dec; 5(24):12480-93. PubMed ID: 24165931
[TBL] [Abstract][Full Text] [Related]
28. Novel cisplatin-incorporated polymeric micelles can eradicate solid tumors in mice.
Nishiyama N; Okazaki S; Cabral H; Miyamoto M; Kato Y; Sugiyama Y; Nishio K; Matsumura Y; Kataoka K
Cancer Res; 2003 Dec; 63(24):8977-83. PubMed ID: 14695216
[TBL] [Abstract][Full Text] [Related]
29. Selective intracellular delivery of proteasome inhibitors through pH-sensitive polymeric micelles directed to efficient antitumor therapy.
Quader S; Cabral H; Mochida Y; Ishii T; Liu X; Toh K; Kinoh H; Miura Y; Nishiyama N; Kataoka K
J Control Release; 2014 Aug; 188():67-77. PubMed ID: 24892974
[TBL] [Abstract][Full Text] [Related]
30. [Studies on antitumor activities and pulmonary toxicity of pepleomycin sulfate (NK631) (author's transl)].
Ebihara K; Ekimoto H; Itchoda Y; Abe F; Inoue H; Aoyagi S; Yamashita T; Koyu A; Takahashi K; Yoshioka O; Matsuda A
Jpn J Antibiot; 1978 Dec; 31(12):872-85. PubMed ID: 83410
[TBL] [Abstract][Full Text] [Related]
31. [Advances in the study of tumor pH-responsive polymeric micelles for cancer drug targeting delivery].
Xu JX; Tang JB; Zhao LH; Shen YQ
Yao Xue Xue Bao; 2009 Dec; 44(12):1328-35. PubMed ID: 21351464
[TBL] [Abstract][Full Text] [Related]
32. Cyclic RGD-linked polymeric micelles for targeted delivery of platinum anticancer drugs to glioblastoma through the blood-brain tumor barrier.
Miura Y; Takenaka T; Toh K; Wu S; Nishihara H; Kano MR; Ino Y; Nomoto T; Matsumoto Y; Koyama H; Cabral H; Nishiyama N; Kataoka K
ACS Nano; 2013 Oct; 7(10):8583-92. PubMed ID: 24028526
[TBL] [Abstract][Full Text] [Related]
33. In vivo pharmacokinetics, biodistribution and antitumor effect of amphiphilic poly(L-amino acids) micelles loaded with a novel all-trans retinoic acid derivative.
Tang J; Wang X; Wang T; Chen F; Zhou J
Eur J Pharm Sci; 2014 Jan; 51():157-64. PubMed ID: 24076464
[TBL] [Abstract][Full Text] [Related]
34. Forodesine in the treatment of cutaneous T-cell lymphoma.
Lewis DJ; Duvic M
Expert Opin Investig Drugs; 2017 Jun; 26(6):771-775. PubMed ID: 28447489
[TBL] [Abstract][Full Text] [Related]
35. Polymeric micellar delivery systems in oncology.
Matsumura Y
Jpn J Clin Oncol; 2008 Dec; 38(12):793-802. PubMed ID: 18988667
[TBL] [Abstract][Full Text] [Related]
36. Polymeric micelles as a new drug carrier system and their required considerations for clinical trials.
Yokoyama M
Expert Opin Drug Deliv; 2010 Feb; 7(2):145-58. PubMed ID: 20095939
[TBL] [Abstract][Full Text] [Related]
37. Antitumor efficacy of dexamethasone-loaded core-crosslinked polymeric micelles.
Coimbra M; Rijcken CJ; Stigter M; Hennink WE; Storm G; Schiffelers RM
J Control Release; 2012 Nov; 163(3):361-7. PubMed ID: 23041274
[TBL] [Abstract][Full Text] [Related]
38. Roles of ligand and TPGS of micelles in regulating internalization, penetration and accumulation against sensitive or resistant tumor and therapy for multidrug resistant tumors.
Wang AT; Liang DS; Liu YJ; Qi XR
Biomaterials; 2015 Jun; 53():160-72. PubMed ID: 25890716
[TBL] [Abstract][Full Text] [Related]
39. Progress of drug-loaded polymeric micelles into clinical studies.
Cabral H; Kataoka K
J Control Release; 2014 Sep; 190():465-76. PubMed ID: 24993430
[TBL] [Abstract][Full Text] [Related]
40. Efficient delivery of docetaxel for the treatment of brain tumors by cyclic RGD-tagged polymeric micelles.
Li AJ; Zheng YH; Liu GD; Liu WS; Cao PC; Bu ZF
Mol Med Rep; 2015 Apr; 11(4):3078-86. PubMed ID: 25434368
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
